SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BISCAGLIA, Simone
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.631
AS - Asia 7.761
EU - Europa 4.246
SA - Sud America 1.250
Continente sconosciuto - Info sul continente non disponibili 487
AF - Africa 178
OC - Oceania 43
AN - Antartide 1
Totale 26.597
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.165
SG - Singapore 2.855
CN - Cina 1.621
IT - Italia 1.181
BR - Brasile 973
VN - Vietnam 876
DE - Germania 746
HK - Hong Kong 579
BD - Bangladesh 567
GB - Regno Unito 397
FI - Finlandia 394
FR - Francia 355
CA - Canada 230
JP - Giappone 228
IN - India 216
PL - Polonia 216
TR - Turchia 214
SE - Svezia 186
UA - Ucraina 163
RU - Federazione Russa 160
ID - Indonesia 147
MX - Messico 142
NL - Olanda 105
AR - Argentina 96
ES - Italia 80
ZA - Sudafrica 79
IQ - Iraq 64
CO - Colombia 45
PK - Pakistan 45
EC - Ecuador 43
AU - Australia 41
PH - Filippine 38
BE - Belgio 37
KR - Corea 37
AT - Austria 36
MY - Malesia 36
LT - Lituania 30
VE - Venezuela 30
UZ - Uzbekistan 27
SA - Arabia Saudita 26
EG - Egitto 25
IR - Iran 25
JM - Giamaica 24
CH - Svizzera 22
AE - Emirati Arabi Uniti 19
IE - Irlanda 19
CL - Cile 17
CZ - Repubblica Ceca 17
KE - Kenya 16
MA - Marocco 15
TH - Thailandia 15
TW - Taiwan 13
UY - Uruguay 13
PY - Paraguay 12
CR - Costa Rica 11
HR - Croazia 11
IL - Israele 11
JO - Giordania 11
NI - Nicaragua 11
PE - Perù 11
PT - Portogallo 11
RO - Romania 11
DO - Repubblica Dominicana 9
KZ - Kazakistan 9
NP - Nepal 9
PS - Palestinian Territory 9
AL - Albania 8
DZ - Algeria 8
PA - Panama 8
TN - Tunisia 8
CY - Cipro 7
DK - Danimarca 7
HN - Honduras 7
LB - Libano 7
NO - Norvegia 7
BH - Bahrain 6
ET - Etiopia 6
KG - Kirghizistan 6
KW - Kuwait 6
MT - Malta 6
SV - El Salvador 6
AZ - Azerbaigian 5
GE - Georgia 5
LV - Lettonia 5
SN - Senegal 5
TT - Trinidad e Tobago 5
BO - Bolivia 4
CI - Costa d'Avorio 4
EE - Estonia 4
GT - Guatemala 4
GY - Guiana 4
OM - Oman 4
SI - Slovenia 4
BB - Barbados 3
BG - Bulgaria 3
BY - Bielorussia 3
CG - Congo 3
HU - Ungheria 3
LI - Liechtenstein 3
MD - Moldavia 3
Totale 26.059
Salva come PNG Salva come JPEG
Città #
Ashburn 1.790
Singapore 1.693
San Jose 1.216
Fairfield 755
Woodbridge 565
Hong Kong 554
Santa Clara 522
Beijing 512
Council Bluffs 497
Houston 463
Munich 441
New York 365
Los Angeles 337
Chandler 335
Seattle 318
Ann Arbor 299
Wilmington 291
Ho Chi Minh City 288
Dallas 287
Cambridge 265
Helsinki 259
Tokyo 210
Warsaw 204
Milan 190
Jacksonville 187
Hanoi 185
Lauterbourg 144
São Paulo 121
Shanghai 110
Princeton 96
Izmir 95
London 95
Orem 93
Ferrara 88
Chicago 87
Jakarta 86
Phoenix 83
Nanjing 82
Atlanta 78
Toronto 71
Turku 71
Buffalo 70
Mexico City 69
San Diego 69
Rome 66
Brooklyn 59
Chennai 57
Montreal 57
Frankfurt am Main 56
Da Nang 47
Denver 46
Stockholm 46
Mumbai 41
Boston 40
Johannesburg 40
Bologna 39
Amsterdam 38
Haiphong 38
Nuremberg 38
Brussels 37
Hefei 37
Manchester 37
San Francisco 37
The Dalles 37
Poplar 35
Boardman 33
Moscow 33
Rio de Janeiro 33
Tianjin 31
Bremen 29
Falls Church 28
Salt Lake City 27
Washington 25
Columbus 24
Paris 24
Tashkent 24
Ankara 23
Nanchang 23
Turin 23
Quito 22
Melbourne 21
Charlotte 20
New Delhi 20
Redwood City 19
Belo Horizonte 18
Des Moines 18
Guangzhou 18
Lappeenranta 18
Shenzhen 18
Baghdad 17
Changsha 17
Newark 17
Norwalk 17
Shenyang 17
Biên Hòa 16
Brasília 16
Jiaxing 16
Naples 16
Querétaro 16
Schiffdorf 16
Totale 16.317
Salva come PNG Salva come JPEG
Nome #
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology 439
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 436
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial 382
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 370
Exercise Intervention to Improve Functional Capacity in Older Adults After Acute Coronary Syndrome 361
Diagnostic accuracy of baseline troponin and troponin change for the diagnosis of myocardial infarction complicated with heart failure 327
Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study) 303
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study 299
Prospective identification of stent fracture by enhanced stent visualization system during percutaneous coronary intervention 291
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 289
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 282
Reperfusion Damage - A Story of Success, Failure, and Hope 272
Endotypes of angina with non-obstructive coronary arteries: a prospective multicentre study 271
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 269
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 267
Bleeding Risk Scores and Scales of Frailty for the Prediction of Haemorrhagic Events in Older Adults with Acute Coronary Syndrome: Insights from the FRASER study 266
Uric acid and coronary artery disease: An elusive link deserving further attention 262
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease 260
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 254
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 253
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials 251
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study 247
Adenosine-Free Indexes vs. Fractional Flow Reserve for Functional Assessment of Coronary Stenoses: Systematic Review and Meta-Analysis 242
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 236
Nutritional status and all-cause mortality in older adults with acute coronary syndrome 231
Angina and left ventricular dysfunction: can we "reduce' it? 231
Angio-based index of microcirculatory resistance for the assessment of the coronary resistance: A proof of concept study 229
Contrast Associated Acute Kidney Injury and Mortality in Older Adults with Acute Coronary Syndrome: A Pooled Analysis of the FRASER and HULK Studies 229
Can we improve myocardial protection during ischaemic injury? 225
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 223
Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial 223
BRS implantation in long lesions requiring device overlapping: Myth or reality? 221
Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease 220
10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction 213
Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter “real-world” registry 210
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) 209
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 204
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention 204
Ticagrelor improves endothelial function by decreasing circulating Epidermal Growth Factor (EGF) 203
Exercise intervention improves quality of life in older adults after myocardial infarction: randomised clinical trial 203
Fractional flow reserve: Current applications and overview of the available data 201
Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry 201
QFR-Based Virtual PCI or Conventional Angiography to Guide PCI: The AQVA Trial 200
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study 200
Angina and chronic obstructive pulmonary disease: facing the perfect storm 200
Coronary Physiology Guidance vs. Conventional Angiography for Optimization of Percutaneous Coronary Intervention: the AQVA II Trial 198
Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplasty 196
Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials 192
Acetylcholine Use in Modern Cardiac Catheterization Laboratories: A Systematic Review 191
Functional (Re)Development of SYNTAX Score II 2020: Predictive Performance and Risk Assessment 190
Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study 190
Role of the tricuspid regurgitation after mitraclip and transcatheter aortic valve implantation: A systematic review and meta-analysis 187
Prognostic Value of QFR Measured Immediately After Successful Stent Implantation: The International Multicenter Prospective HAWKEYE Study 186
Impact of trans-stent gradient on outcome after PCI: results from a HAWKEYE substudy 185
QFR for the Revascularization of Nonculprit Vessels in MI Patients: Insights From the FIRE Trial 184
Clinical Outcome of FFR-Guided Revascularization Strategy of Coronary Lesions: The HALE-BOPP Study 180
"Safe Femoral" Artery Approach in Endovascular Procedures: A Systematic Review of Its Safety and Feasibility 179
The impact of the 3-year ABSORB II trial results on my clinical practice: An Italian survey 178
Comparison of quantitative flow ratio, Pd/Pa and diastolic hyperemia-free ratio versus fractional flow reserve in non-culprit lesion of patients with non ST-segment elevation myocardial infarction 177
Angio-Based Fractional Flow Reserve, Functional Pattern of Coronary Artery Disease, and Prediction of Percutaneous Coronary Intervention Result: a Proof-of-Concept Study 176
Coronary Sinus Narrowing Improves Coronary Microcirculation Function in Patients With Refractory Angina: A Multicenter Prospective INROAD Study 175
Fractional flow reserve implementation in daily clinical practice: A European survey 175
Functional coronary angiography to indicate and guide revascularization in STEMI patients with multivessel disease: Rationale and design of the AIR-STEMI trial 173
Dual Antiplatelet Therapy in Patients with Glucose-6-Phosphate Dehydrogenase Deficiency undergoing PCI with Drug-Eluting Stents. 173
Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease 172
Same-day transfer for the invasive strategy of patients with non-ST-segment elevation acute coronary syndrome admitted to spoke hospitals: Data from the Emilia-Romagna Regional Network 170
Coronary Computed Tomography Angiography for the Assessment of Sirolimus-Eluting Resorbable Magnesium Scaffold 169
Multidomain Rehabilitation for Older Patients with Myocardial Infarction 169
Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure 169
Bioresorbable vascular scaffold overlap evaluation with optical coherence tomography after implantation with or without enhanced stent visualization system (WOLFIE study): a two-centre prospective comparison 167
Ten-year prognostic impact of target versus non-target vessel failure after STEMI. Insight from the EXAMINATION-EXTEND trial 164
Lipid Plaque Burden in NSTE-ACS patients with or without COPD: insights from the SCAP trial 163
Short- Versus Long-Term Duration of Dual Antiplatelet Therapy in Patients Treated for In-Stent Restenosis: A PRODIGY Trial Substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) 159
#FullPhysiology: a systematic step-by-step guide to implement intracoronary physiology in daily practice 158
Acute myocardial infarction and large coronary thrombosis in a patient with COVID-19 155
30-Day DAPT in Patients at High Bleeding Risk Undergoing PCI With Biodegradable-Polymer Sirolimus-Eluting Ultra-Thin Stent 154
Transradial coronary catheterization and intervention across the whole spectrum of Allen test results 154
Index of microcirculatory resistance assessment in patients with new diagnosis of left ventricular dilatation without significant coronary artery lesions: IMPAIRED pilot trial 154
Age and Outcomes in TAVR Patients: Are We Barking Up the Wrong Tree? 154
Enhanced stent visualization systems during PCI: A case series and review of literature 151
Relationship between physical activity and long-term outcomes in patients with stable coronary artery disease 150
Remodelling after an Infarct: Crosstalk between Life and Death 148
Comparison of quantitative flow ratio, Pd/Pa, and diastolic hyperaemia-free ratio vs. fractional flow reserve in non-culprit lesion of patients with non-ST-segment elevation myocardial infarction 148
Optical coherence tomography evaluation of overlapping everolimus-eluting bioresorbable vascular scaffold implantation guided by enhanced stent visualization system 144
Neural interfaces to monitor Interventional Cardiologists' mental workload: GAME-ON SAGA 143
Complete versus culprit-only strategy in older MI patients with multivessel disease 141
Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis 140
Seven french radial artery access for PCI: A prospective single-center experience 140
Impact of pre-admission physical activity on benefits of physiology-guided complete revascularization in older patients with myocardial infarction: insights from the FIRE trial 139
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU (Gauging coronary Healing with bioresorbable Scaffolding plaTforms in EUrope) Registry 139
Functional Assessment and Acute Coronary Syndrome 137
Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction and High Bleeding Risk: A Randomized Clinical Trial 136
Short term outcome following acute phase switch among P2Y12 inhibitors in patients presenting with acute coronary syndrome treated with PCI: A systematic review and meta-analysis including 22,500 patients from 14 studies 135
Combined use of intra-aortic balloon pump and impella in cardiogenic shock: A systematic review 134
Complete vs. culprit-only strategy in older MI patients with multi-vessel disease 133
CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY FOR THE ASSESSMENT OF SIROLIMUS-ELUTING RESORBABLE MAGNESIUM SCAFFOLD 133
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets 132
Extracorporeal Circulatory Support in Acute Coronary Syndromes: A Systematic Review and Meta-Analysis 131
The impact of periprocedural myocardial infarction on mortality in older adults with non-ST-segment elevation acute coronary syndrome: a pooled analysis of the FRASER and HULK studies 131
Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction With or Without ST-Segment Elevation 131
Totale 20.441
Salva come PNG Salva come JPEG
Categoria #
all - tutte 120.163
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.163
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022839 0 0 78 43 46 58 56 72 45 78 124 239
2022/2023876 105 55 50 69 128 120 69 72 120 8 58 22
2023/2024899 48 68 36 19 64 147 53 96 23 59 76 210
2024/20254.596 112 104 281 238 507 449 338 270 820 451 565 461
2025/202612.821 1.045 464 1.003 1.403 1.663 764 1.351 717 1.312 1.454 859 786
2026/20271.964 640 907 417 0 0 0 0 0 0 0 0 0
Totale 26.597